Journal details
ALZHEIMERS RESEARCH & THERAPY
BMC · eISSN 1758-9193
SCIEScopusMEDLINEPubMedPMCDOAJ
Overview
ALZHEIMERS RESEARCH & THERAPY. eISSN 1758-9193. published by BMC. England. Clinical Neurology · Neurosciences. impact factor 8.9 (2025). JCR Q1. CAS Zone 1 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 159 articles · 2025: 294 articles · 2024: 279 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of ALZHEIMERS RESEARCH & THERAPY?
The impact factor recorded for ALZHEIMERS RESEARCH & THERAPY is 8.9 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of ALZHEIMERS RESEARCH & THERAPY?
ALZHEIMERS RESEARCH & THERAPY is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index ALZHEIMERS RESEARCH & THERAPY?
ALZHEIMERS RESEARCH & THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.